应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
09995 荣昌生物
休市中 10-16 16:08:16
65.900
+1.050
+1.62%
最高
67.700
最低
65.000
成交量
218.43万
今开
65.000
昨收
64.850
日振幅
4.16%
总市值
371.42亿
流通市值
137.46亿
总股本
5.64亿
成交额
1.45亿
换手率
1.05%
流通股本
2.09亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
荣昌生物制药（09995）拟于10月29日审议截至9月30日止九个月未经审计业绩
公告速递 · 10-16 16:37
荣昌生物制药（09995）拟于10月29日审议截至9月30日止九个月未经审计业绩
【券商聚焦】中信建投：ESMO中国研究入选创新高 梳理医药细分板块机会
金吾财讯 · 10-16 09:27
【券商聚焦】中信建投：ESMO中国研究入选创新高 梳理医药细分板块机会
异动解读｜荣昌生物盘中下跌5.03%，3.7亿元购买浦发银行理财产品
行情直击 · 10-15
异动解读｜荣昌生物盘中下跌5.03%，3.7亿元购买浦发银行理财产品
【券商聚焦】中信建投：AI重塑药物研发 2035年全球市场有望破460亿美元
金吾财讯 · 10-15
【券商聚焦】中信建投：AI重塑药物研发 2035年全球市场有望破460亿美元
资金动向 | 北水抢筹阿里11.9亿港元，连续12日减持中芯国际
格隆汇 · 10-14
资金动向 | 北水抢筹阿里11.9亿港元，连续12日减持中芯国际
荣昌生物(09995)10月14日再投3.7亿元购入浦发银行理财产品
公告速递 · 10-14
荣昌生物(09995)10月14日再投3.7亿元购入浦发银行理财产品
荣昌生物：拟使用3.7亿元购买浦发银行理财产品
南方财经网 · 10-14
荣昌生物：拟使用3.7亿元购买浦发银行理财产品
荣昌生物(09995.HK)：购买理财产品
智通财经 · 10-14
荣昌生物(09995.HK)：购买理财产品
荣昌生物（688331）10月13日主力资金净卖出1195.87万元
证券之星 · 10-14
荣昌生物（688331）10月13日主力资金净卖出1195.87万元
荣昌生物（688331）10月8日主力资金净卖出6852.23万元
证券之星 · 10-09
荣昌生物（688331）10月8日主力资金净卖出6852.23万元
荣昌生物（09995）披露首次回购进展：已耗资约663.20万元回购60,040股
公告速递 · 10-08
荣昌生物（09995）披露首次回购进展：已耗资约663.20万元回购60,040股
荣昌生物(09995)截至9月末累计回购6万股
智通财经 · 10-08
荣昌生物(09995)截至9月末累计回购6万股
荣昌生物更新2026年9月股份变动月报表，股本维持稳定
公告速递 · 10-06
荣昌生物更新2026年9月股份变动月报表，股本维持稳定
【券商聚焦】国金证券：行业有望迎业绩与估值戴维斯双击，创新药板块底部配置价值凸显
金吾财讯 · 10-05
【券商聚焦】国金证券：行业有望迎业绩与估值戴维斯双击，创新药板块底部配置价值凸显
港股异动 | 创新药概念股回落 诺诚健华(09969.HK)跌超8% 荣昌生物(09995.HK)跌近6%
智通财经 · 10-02
港股异动 | 创新药概念股回落 诺诚健华(09969.HK)跌超8% 荣昌生物(09995.HK)跌近6%
异动解读｜荣昌生物盘中下跌7.65%，报71.0港元
行情直击 · 10-02
异动解读｜荣昌生物盘中下跌7.65%，报71.0港元
港股异动 | 荣昌生物(09995)尾盘涨超3% 泰它西普治疗gMG中国Ⅲ期临床研究分析结果在AANEM年会公布
智通财经 · 09-30
港股异动 | 荣昌生物(09995)尾盘涨超3% 泰它西普治疗gMG中国Ⅲ期临床研究分析结果在AANEM年会公布
创新药概念股逆市走强 康方生物（09926）涨16.85%、康诺亚-B（02162）涨10.32%
金吾财讯 · 09-29
创新药概念股逆市走强 康方生物（09926）涨16.85%、康诺亚-B（02162）涨10.32%
异动解读｜荣昌生物盘中上涨5.13%，报74.85港元
行情直击 · 09-29
异动解读｜荣昌生物盘中上涨5.13%，报74.85港元
荣昌生物（688331）披露公司秘书及授权代表变更公告，9月28日股价下跌0.81%
证券之星 · 09-28
荣昌生物（688331）披露公司秘书及授权代表变更公告，9月28日股价下跌0.81%
加载更多
公司概况
公司名称：
荣昌生物
所属市场：
SEHK
上市日期：
--
主营业务：
荣昌生物制药（烟台）股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物（ADC）、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。
发行价格：
--
{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":65.9,"timestamp":1792138096010,"preClose":64.85,"halted":0,"volume":2184300,"delay":0,"changeRate":0.01619121048573649,"floatShares":208581239,"shares":563608243,"eps":1.5140661125891741,"marketStatus":"休市中","change":1.05,"latestTime":"10-16 16:08:16","open":65,"high":67.7,"low":65,"amount":145286376,"amplitude":0.041635,"askPrice":65.95,"askSize":500,"bidPrice":65.8,"bidSize":3500,"shortable":3,"etf":0,"ttmEps":12.190502131817073,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":7,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":64.85,"openAndCloseTimeList":[[1792114200000,1792123200000],[1792126800000,1792137600000]],"volumeRatio":1.1328757504139388,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":100,"timestamp":1792134000000,"preClose":99.25,"halted":0,"volume":6608200,"delay":0,"premium":"-43.85"}},"requestUrl":"/m/hq/s/09995","defaultTab":"news","newsList":[{"id":"1146402057","title":"荣昌生物制药（09995）拟于10月29日审议截至9月30日止九个月未经审计业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1146402057","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146402057?lang=zh_cn&edition=full","pubTime":"2026-10-16 16:37","pubTimestamp":1792139836,"startTime":"0","endTime":"0","summary":"荣昌生物制药（烟台）股份有限公司（09995）10月16日公告称，公司董事会拟于2026年10月29日（星期四）召开会议，主要议程包括审议及批准公司及其附属公司截至2026年9月30日止九个月的未经审计第三季度业绩及其刊发事宜。届时，董事会将对相关财务数据进行审阅并决定披露安排。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675546035","title":"【券商聚焦】中信建投：ESMO中国研究入选创新高 梳理医药细分板块机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2675546035","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675546035?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:27","pubTimestamp":1792114033,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券表示，本周制药行业表现一般，2026 ESMO LBA中国研究入选创新高，恒瑞医药、康方生物、艾力斯等企业的管线迎来新进展。医疗器械及服务板块低值耗材表现较好，多受个股事件催化，科技概念标的调整，港股回购活跃；短期关注招标改善和集采出清，中长期看创新、出海、并购。中药板块跑赢申万医药及大盘，关注红利、创新及“四同药品”、中成药集采政策。生物制品板块跑输医药指数及大盘，AI制药、mRNA肿瘤疫苗概念股回调；南北方ILI%均环比降低，南方检测阳性率提升、北方降低。医药商业板块跑赢申万医药及大盘，药店关注三季度前瞻及集采进药店，流通关注回款及三季度前瞻。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993829","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","09926","01177","LU0228659784.USD","SG9999011746.SGD","01877","09688","02616","601066","BK1500","LU1226287792.SGD","02269","LU0823426480.USD","LU1251922891.USD","LU0140636845.USD","LU0819121731.USD","BK1610","LU0181495838.USD","06160","BK1515","LU0540923850.HKD","LU0052750758.USD","BK1583","LU0979878070.USD","SG9999002562.SGD","LU1226287875.USD","LU0072913022.USD","BK1141","LU0348827113.USD","01801","09995","09939","02142","LU0501845795.SGD","LU1951186391.HKD","LU0417516902.SGD","06185","KCE","LU2476274720.SGD","LU0326950275.SGD","LU1969619763.USD","159938","IE00BZ08YR35.GBP","LU0128526141.USD","LU0348767384.USD","LU0634319403.HKD","LU1242518857.USD","LU0359201612.USD","LU0314109678.HKD","01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118500893","title":"异动解读｜荣昌生物盘中下跌5.03%，3.7亿元购买浦发银行理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1118500893","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118500893?lang=zh_cn&edition=full","pubTime":"2026-10-15 13:25","pubTimestamp":1792041931,"startTime":"0","endTime":"0","summary":"10月15日，荣昌生物盘中下跌5.03%，报63.3港元，成交额1.33亿港元。消息面上，公司10月14日公告与浦发银行烟台分行订立两份理财协议，合计投入3.7亿元，其中7000万元为闲置募集资金、3亿元为闲置自有资金，购买保本浮动收益型产品。结合5月已投向同类产品的3亿元，公司12个月内累计使用6.7亿元购买浦发银行理财产品，并因此构成须予披露交易。两款新产品期限分别为69天和30天，预期年化收益率区间为0.7%至1.95%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"荣昌生物盘中下跌，斥3.7亿购理财产品","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675376082","title":"【券商聚焦】中信建投：AI重塑药物研发 2035年全球市场有望破460亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675376082","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675376082?lang=zh_cn&edition=full","pubTime":"2026-10-15 09:00","pubTimestamp":1792026019,"startTime":"0","endTime":"0","summary":"AI深度介入靶点识别、分子设计等药物研发环节，破解传统制药高投入、长周期难题。报告测算，全球AI制药市场2025年规模约24.9亿美元，2035年有望突破460亿美元，CAGR超33%，国内市场具备高增长潜力；科技巨头、药企、CXO等多方入局，海内外多家头部企业完成平台搭建与商业化验证。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993729","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242644610.SGD","CHAT","BK1576","09688","601066","ARTY","BK1141","LU0348825331.USD","IE00B031HY20.USD","LU0456827905.SGD","VTHR","09995","IBBJ","LU2778985437.USD","QTOC","LU0128522744.USD","IE00BZ08YS42.EUR","LU0979878070.USD","AGIX","09926","LU0052750758.USD","LU0456846285.SGD","KURE","LU1152091754.HKD","LU1008478684.HKD","LU0501845795.SGD","LU0516422952.EUR","02269","KCE","06185","06160","AIPO","01801","LU0516422440.USD","BK1500","SG9999002562.SGD","LU1251922891.USD","BK1588","LU0856984785.SGD","LU0128526141.USD","01093","LU0326950275.SGD","02616","LU0516423174.USD","LU0051755006.USD","01177","02142","LU0029874061.USD","LU0588546209.SGD","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675345305","title":"资金动向 | 北水抢筹阿里11.9亿港元，连续12日减持中芯国际","url":"https://stock-news.laohu8.com/highlight/detail?id=2675345305","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675345305?lang=zh_cn&edition=full","pubTime":"2026-10-14 18:44","pubTimestamp":1791974684,"startTime":"0","endTime":"0","summary":"跟踪南向资金最新动态","market":"us","thumbnail":"https://img3.gelonghui.com/172d4-f450b961-d2ec-45f8-96f2-2956cdc54ed8.jpg?guru_height=1664&guru_width=2432&guru_size=642580","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/172d4-f450b961-d2ec-45f8-96f2-2956cdc54ed8.jpg?guru_height=1664&guru_width=2432&guru_size=642580"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6994047","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU1770034418.SGD","LU1880383366.USD","LU0345769631.USD","LU2045819591.USD","LU2778985437.USD","LU0396098781.USD","LU1196710864.SGD","89988","LU1224709979.USD","LU0080751232.USD","LU0192582467.USD","LU0211331839.USD","LU0441854154.USD","LU1688375341.USD","LU1115378108.SGD","LU2087589342.USD","SG9999018857.SGD","LU0345776255.USD","IE00B0169N27.USD","LU0214875030.USD","LU0880133367.SGD","01888","LU0890818403.SGD","LU0128522157.USD","LU2237443465.HKD","LU0823397103.USD","IE00B543WZ88.USD","IE0008368742.USD","IE00BZ08YT58.USD","LU1974910355.USD","LU0589944569.HKD","LU1102505762.USD","HK0000107257.USD","LU1969619763.USD","LU2097829019.USD","LU0449515922.USD","ESPO","LU0572940350.SGD","SG9999001226.SGD","IE00B0JY6N72.USD","LU0164865239.USD","LU0594300179.USD","BK1517","IE00B29SXG58.USD","LU0164872284.USD","HK0000288743.USD","DRGN","LU0541502299.USD","LU2294711473.HKD","IE0008368411.USD","LU0608807946.USD","LU0873338254.USD","BIDD","LU0210526637.USD","LU0531971595.HKD","688331","LU2237443549.SGD","SG9999002463.SGD","IE00BQXX3D17.EUR","LU2488822045.USD","LU1282649067.USD","LU0359201612.USD","LU0127658192.USD","LU0048597586.USD","IE0034224299.USD","IE00BQXX3C00.GBP","IE0001KFT4U8.USD","SG9999001093.SGD","LU1655091459.SGD","LU1196710351.USD","LU0828237940.HKD","LU1226287792.SGD","81810","LU0210533765.USD","LU1008478684.HKD","LU0307460666.USD","LU1720051017.SGD","IE00B067MR52.USD","LU1810669033.SGD","LU0501845795.SGD","LU0823413660.USD","LU2362541513.USD","LU0414403682.SGD","LU0633140560.USD","LU0737861772.HKD","LU0650527681.SGD","LU0264606111.USD","LU1323998911.USD","LU0823038988.USD","LU1251922891.USD","LU0577902611.USD","BK1516","LU0169518387.USD","LU2097828714.EUR","LU0797268264.HKD","LU2148510915.USD","LU0819123356.HKD","LU2097828474.EUR","LU0823426480.USD","LU0254981946.USD","LU1439103000.SGD","LU0786609619.USD","LU2476274308.USD","LU0871576103.HKD","LU0175139822.USD","LU0370786039.SGD","LU0972618739.USD","LU0823041008.USD","LU1044876610.USD","LU2237443622.USD","SG9999017495.SGD","LU0488056044.USD","LU1316542783.SGD","LU1328615791.USD","LU2247934214.USD","LU0251144936.SGD","LU1242518931.SGD","LU1769817179.HKD","BK1583","HK0001040143.USD","LU1725190679.HKD","SGXZ31699556.SGD","LU0469268626.HKD","LU2498475776.HKD","SG9999002828.SGD","SG9999001903.USD","LU0203345920.USD","LU0106959298.USD","LU1044874839.SGD","BK1163","BK1591","LU0348825331.USD","IE00BF5LJ272.USD","LU1046422090.SGD","LU0130103400.USD","LU0648948544.HKD","KWEB","LU0314109678.HKD","LU1064130708.USD","LU1235295612.USD","LU2462611646.USD","LU0274383008.USD","601869","LU0672654166.SGD","SG9999006514.SGD","LU0651946864.USD","LU0588545490.SGD","LU0516422952.EUR","LU0823426308.USD","LU0326948709.USD","HK0000288784.HKD","LU0143863198.USD","LU1770036033.HKD","SG9999004220.SGD","BK1506","SG9999001689.USD","LU1720051108.HKD","LU0979878070.USD","HK0000320223.HKD","LU2226246903.HKD","BK1249","LU0231483743.USD","IE00BZ08YS42.EUR","LU1548497426.USD","BK1609","LU2152927971.USD","BK1193","FDNI","LU0502904849.HKD","LU1568876251.USD","LU0163747925.USD","LU2449936058.SGD","LU0072462343.USD","LU2265009873.SGD","LU0784639295.USD","ODDS","LU0828238088.HKD","LU1303224171.USD","LU0320764243.SGD","LU2399975544.HKD","LU0320764755.SGD","IE00BPRC5H50.USD","BK1149","LU0315179316.USD","IE0003895053.USD","LU0329678170.USD","HXXD.SI","LU0029875118.USD","LU0516422440.USD","LU1504937902.USD","LU2187417386.USD","LU0235996351.USD","SG9999001069.SGD","LU1105468828.SGD","00981","LU1675838814.USD","LU0061477393.USD","LU0345769128.USD","LU0831103253.SGD","LU1808992512.USD","GAMR","LU0211977185.USD","LU0049853897.USD","LU1733274390.USD","09988","LU0228367735.SGD","LU1282651121.HKD","LU1794554557.SGD","SG9999014898.SGD","BK1604","LU1804176565.USD","HK0000306685.HKD","LU0196878994.USD","LU0348814723.USD","BK1589","LU0315178854.USD","09995","SG9999014674.SGD","LU0819121731.USD","IE00BGV7N243.SGD","IE00B031J352.USD","IE00BMPRXN33.USD","LU0878004406.USD","GB00BDT5M118.USD","LU1733274473.HKD","00700","JEMA","LU0499858438.USD","LU0577902371.SGD","BKF","BK1575","LU0572944931.SGD","BK1586","LU0499858602.USD","LU0417516902.SGD","LU0345775950.USD","LU0737861699.HKD","SG9999001051.SGD","LU1734074674.USD","LU1831875114.USD","LU0823039010.USD","LU2125910500.SGD","LU0918141887.USD","LU1691799644.USD","HMTD.SI","LU1515016050.SGD","LU0608807433.USD","LU0509642566.USD","LU2293587155.HKD","LU1064131003.USD","SG9999002562.SGD","LU0197773160.USD","SGXZ51526630.SGD","LU1814569148.SGD","LU0594300419.USD","LU0455707207.USD","LU0918141705.HKD","LU1880383440.USD","LU0348827113.USD","FFEM","LU0203347892.USD","SG9999000327.SGD","SG9999006597.SGD","TCHI","LU0611395673.USD","LU1880398554.USD","HK0000320264.USD","LU2039709279.SGD","CXSE","XIACY","LU1629966141.USD","IE00B97KM107.HKD","LU0052750758.USD","LU0878005551.USD","EMCS","TCEHY","LU0039217434.USD","METmain","LU0269904917.USD","LU0431992006.USD","LU0856984785.SGD","SG9999015945.SGD","IE0008369823.USD","LU0228659784.USD","LU0449509016.USD","LU0821914370.USD","BK1170","LU0067412154.USD","LU0882747503.HKD","BK1142","LU1282651048.USD","LU2097828631.EUR","LU0084288322.USD","LU0047713382.USD","IE00B031HW06.USD","LU0384037296.USD","SGXZ81514606.USD","LU0143863784.USD","IE00BMPRXR70.SGD","LU0577902454.USD","LU0348783233.USD","BK1531","LU0516423174.USD","LU1883866441.USD","LU2242644610.SGD","BK1523","LU0049112450.USD","LU1102505929.USD","LU0862451753.SGD","LU2351347302.SGD","LU2106854487.HKD","LU0417516571.SGD","IE0031814852.USD","IE0032834883.USD","LU0070217475.USD","IE0032431581.USD","BK1588","IE0003851619.USD","LU2237443382.USD","LU1769817096.USD","LU1023057109.AUD","LU1282648689.USD","LU0329678337.USD","SG9999000418.SGD","LU0348783662.USD","LU0348788117.USD","LU0048580855.USD","SG9999014914.USD","LU0328353924.USD","LU0577902538.SGD","SG9999007991.SGD","LU0456846285.SGD","LU0543330483.HKD","LU0593848301.USD","HK0000151867.HKD","LU0675040207.SGD","LU0348816934.USD","LU0985320562.USD","LU1048596156.SGD","LU0072913022.USD","LU0540923850.HKD","LU2023250504.SGD","LU0588546209.SGD","LU2357305700.SGD","LU0140636845.USD","LU0043850808.USD","IE00B031HY20.USD","LU0348805143.USD","LU1366334578.USD","LU1226288097.SGD","LU0605514214.HKD","LU3063872942.SGD","LU2237443895.HKD","LU2317271919.USD","TCHmain","LU2362541273.HKD","LU0259732245.USD","HTCD.SI","LU1051768304.USD","IE0003795394.USD","LU2328871848.SGD","LU0132412106.USD","LU0577902298.EUR","SG9999001846.SGD","BK1501","LU2008162690.USD","LU0348784397.USD","LU0456842615.SGD","LU0229945570.USD","LU0165289439.USD","BK1233","LU1226287529.USD","HK0000352382.USD","IE00B8L5B284.USD","SG9999015952.SGD","LU0708995583.HKD","SOCL","LU0029874905.USD","LU0117841782.USD","SGXZ99366536.SGD","IE00BZ08YR35.GBP","LU1224444064.USD","LU1951186391.HKD","LU0898667661.SGD","LU2097828805.USD","HK0000306701.USD","LU1719994722.HKD","LU2257852520.SGD","LU1044875133.USD","LU1188198961.HKD","LU0634319403.HKD","LU1956131251.USD","HK0000165453.HKD","LU0130518102.USD","BK1610","LU2237443978.SGD","LU0054450605.USD","LU0181495838.USD","BK1607","BK1615","EMC","LU0633140727.USD","LU0762540952.USD","BK1161","LU0700851271.USD","LU2177674079.SGD","IE00B5MMRT66.SGD","688981","HK0000914660.USD","LU0197773673.USD","LU1720050803.USD","LU1961090484.USD","LU2051468812.USD","BABA","LU0477156797.USD","EEMX","IE00B8HQ1Z84.USD","LU1201861165.SGD","LU1211504680.USD","LU0106252389.USD","LU0543330566.HKD","LU0683595622.HKD","LU1807302812.USD","LU2133065610.SGD","LU0516423091.SGD","LU0516422366.SGD","LU0244354667.USD","LU0738912210.USD","SG9999003461.SGD","LU0359201885.HKD","06869","LU1282649810.SGD","LU0588545730.USD","LU0862451837.USD","LU0287142896.SGD","LU1868837565.USD","LU1868838027.USD","LU1366334651.USD","LU2125910849.SGD","LU0648000940.SGD","LU1642822792.SGD","LU1282649141.HKD","LU1152091754.HKD","LU1718418525.SGD","LU1868837722.USD","HK0000286598.CNH","LU0823413587.USD","SG9999015986.USD","HK0000352291.HKD","MPNGY","LU1981816686.USD","LU0886674414.USD","LU3227948356.SGD","SGXZ86797644.SGD","LU0531970944.HKD","LU0762542818.HKD","LU0708995153.HKD","IE00BQXX3F31.USD","LU0588545904.SGD","LU0791590937.USD","SG9999000459.SGD","IE0008368304.USD","LU0327786744.USD","SGXZ90724238.SGD","LU0417516738.SGD","LU0640798160.USD","LU1048484197.HKD","LU1880398471.USD","SGXZ62798434.SGD","BK1095","LU2476274720.SGD","HBBD.SI","LU1813983027.USD","03690","LU0117844026.USD","LU0128522744.USD","LU0828237510.HKD","BK1526","FPA","LU2251237488.HKD","LU1960683339.HKD","LU1439102457.SGD","BK1584","AAXJ","LU1048588211.SGD","LU0868486357.SGD","LU0096374516.USD","LU0048388663.USD","LU1226287875.USD","LU0149534421.HKD","LU0261947096.USD","LU1242518857.USD","LU0359202008.SGD","IE00B3M56506.USD","LU2279858448.HKD","LU1226288253.USD","LU0293314216.USD","LU0320764599.SGD","BK1608","LU0210527791.USD","01810","ALBmain","LU1206782309.USD","LU0823397285.USD","LU0791591158.USD","LU1328277881.USD","LU0456827905.SGD","LU0572939691.SGD","LU0106259558.USD","LU2097828557.USD","LU2251237306.USD","LU1226288170.HKD","LU0630378692.HKD","LU1568876335.HKD","SG9999018865.SGD","MIUmain","LU0188438112.USD","LU0651947912.USD","LU0561508036.HKD","LU0054237671.USD","LU0865486749.SGD","LU0051755006.USD","MCHS","HK0001040168.HKD","LU0107464264.USD","LU0164880469.USD","IE0009570106.USD","LU2279701549.SGD","LU0463099449.HKD","LU0642271901.SGD","SG9999015978.USD","LU0289960550.SGD","LU1785774172.SGD","LU0607220059.USD","LU1196710195.USD","BK1614","LU0348723411.USD","XSOE","SG9999014880.SGD","JADE","LU0326950275.SGD","LU0630378429.USD","LU2929501877.USD","LU0348735423.USD","LU0823040885.USD","LU0173614495.USD","LU0149721374.USD","LU1152091168.USD","LU0011963245.USD","LU0261950983.USD","LU0762541174.USD","LU1171460220.USD","LU1917777945.USD","BK1574","LU0831093199.SGD","LU1481107354.HKD","LDEM","LU0541501648.USD","SG9999013353.USD","LU1993786604.SGD","IE00B0169L03.USD","BK1502","SG9999014906.USD","BK1618","LU1051769294.HKD","HK0000914686.HKD","LU2362540622.SGD","BK1521"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1127759469","title":"荣昌生物(09995)10月14日再投3.7亿元购入浦发银行理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1127759469","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127759469?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:32","pubTimestamp":1791970331,"startTime":"0","endTime":"0","summary":"荣昌生物制药（烟台）股份有限公司10月14日在港交所公告称，公司当日与上海浦东发展银行股份有限公司烟台分行签订两份理财产品协议，合计投入闲置资金3.7亿元人民币。浦发银行烟台分行享有提前终止权，其他条款经双方协商一致确定。截至目前，公司已于2026年5月6日、5月13日分别与浦发银行烟台分行签订5号、7号协议，投入资金2亿元和1亿元，且相关理财产品仍在持有期内。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675310149","title":"荣昌生物：拟使用3.7亿元购买浦发银行理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2675310149","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675310149?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:31","pubTimestamp":1791970268,"startTime":"0","endTime":"0","summary":"南财智讯10月14日电，荣昌生物（09995.HK）发布须予披露交易公告，公司于2026年10月14日与浦发银行烟台分行订立理财产品12号协议及13号协议，分别使用7000万元闲置募集资金和3亿元闲置自有资金购买理财产品。结合此前交易，公司12个月内累计使用6.7亿元购买浦发银行理财产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://money.eastmoney.com/a/202610143895548313.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://money.eastmoney.com/a/202610143895548313.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK0086","BK0201","LU1979443071.USD","LU1064131003.USD","LU2488822045.USD","LU1808992512.USD","BK0015","LU2148510915.USD","688331","BK0278","LU1934453819.USD","LU1064130708.USD","BK0239","BK1161","09995","BK0183","LU2328871848.SGD","LU1969619763.USD","BK0188","600000","BK1583","SGXZ49509284.SGD","BK0028","BK0187","SGXZ81163826.USD","LU0469268626.HKD","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675317284","title":"荣昌生物(09995.HK)：购买理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2675317284","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675317284?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:28","pubTimestamp":1791970114,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09995","LU1969619763.USD","LU2328871848.SGD","BK1583","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675239579","title":"荣昌生物（688331）10月13日主力资金净卖出1195.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675239579","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675239579?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:24","pubTimestamp":1791937490,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月13日收盘，荣昌生物报收于104.75元，下跌3.82%，换手率1.27%，成交量4.5万手，成交额4.7亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入4235.58万元，融资偿还4833.14万元，融资净偿还597.55万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400007149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","LU2488822045.USD","688331","BK1574","BK0239","LU1969619763.USD","LU1064131003.USD","LU2148510915.USD","LU2328871848.SGD","BK1583","09995","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674889467","title":"荣昌生物（688331）10月8日主力资金净卖出6852.23万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674889467","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674889467?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:34","pubTimestamp":1791506055,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，荣昌生物报收于111.21元，下跌5.22%，换手率2.02%，成交量7.2万手，成交额8.12亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入7868.19万元，融资偿还7793.77万元，融资净买入74.42万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900006266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1969619763.USD","BK0239","LU2148510915.USD","09995","BK1161","BK1574","LU2488822045.USD","LU2328871848.SGD","BK1583","LU1064131003.USD","LU1064130708.USD","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142518722","title":"荣昌生物（09995）披露首次回购进展：已耗资约663.20万元回购60,040股","url":"https://stock-news.laohu8.com/highlight/detail?id=1142518722","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142518722?lang=zh_cn&edition=full","pubTime":"2026-10-08 17:31","pubTimestamp":1791451897,"startTime":"0","endTime":"0","summary":"荣昌生物制药（烟台）股份有限公司10月9日公告，截至2026年9月30日，公司已通过上海证券交易所交易系统以集中竞价方式累计回购公司股份60,040股，占公司总股本564,477,483股的0.0106%。本次回购已支付资金人民币6,631,956元，折合约663.20万元，成交价格区间为108.30元/股至113.70元/股。公司表示，后续将按照《上市公司股份回购规则》及相关规定，结合市场情况继续实施回购，并及时履行信息披露义务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673707882","title":"荣昌生物(09995)截至9月末累计回购6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673707882","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673707882?lang=zh_cn&edition=full","pubTime":"2026-10-08 17:27","pubTimestamp":1791451634,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荣昌生物(09995)发布公告，截至2026年9月30日，公司通过上海证券交易所交易系统以集中竞价交易方式累计回购公司股份6万股，占公司总股本5.64亿股的比例为0.0106%，回购成交的最高价为113.7元/股，最低价为108.30元/股，支付的资金总额为人民币663.2万元(不含交易佣金等交易费用)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504672.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1064131003.USD","LU2328871848.SGD","688331","BK1574","LU2148510915.USD","BK0239","BK1583","LU1064130708.USD","BK1161","LU2488822045.USD","09995","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178923130","title":"荣昌生物更新2026年9月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1178923130","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178923130?lang=zh_cn&edition=full","pubTime":"2026-10-06 16:46","pubTimestamp":1791276416,"startTime":"0","endTime":"0","summary":"荣昌生物2026年10月6日公布了截至2026年9月30日的股份变动月报表。报告显示，公司法定/注册股本总额为人民币564,477,483元，其中包括H股与A股两类股份。本月H股数量为208,581,239股，面值每股人民币1元，总股本未发生变化。A股数量为355,896,244股，面值每股人民币1元，总股本同样保持不变。报告期内，公司于2026年9月11日以每股人民币113.434元购回19,000股A股，并作为库存股持有。截至本月末，A股已发行股份降至355,642,060股，库存股相应增加至254,184股，总股本仍为355,896,244股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673792787","title":"【券商聚焦】国金证券：行业有望迎业绩与估值戴维斯双击，创新药板块底部配置价值凸显","url":"https://stock-news.laohu8.com/highlight/detail?id=2673792787","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673792787?lang=zh_cn&edition=full","pubTime":"2026-10-05 08:50","pubTimestamp":1791161445,"startTime":"0","endTime":"0","summary":"随着后续管线商业化兑现、全球创新价值链话语权提升，行业有望迎来业绩与估值的戴维斯双击，创新药板块底部配置价值凸显。中国研究占全体大会核心LBA总量的1/3，这标志着中国肿瘤创新研发已深度融入全球研发体系，成为驱动全球肿瘤诊疗升级的重要力量，持续利好国内创新药企国际化发展与临床价值兑现。2026 ESMO已公布LBA标题，29项LBA的试验药物由中国药企原研或参与开发，涉及约20家企业，其中5项进入主席研讨会。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992996","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0043850808.USD","LU0516422952.EUR","09926","01801","KURE","LU0856984785.SGD","IBBQ","KCE","LU0315179316.USD","LU0823426480.USD","HK0000165453.HKD","09688","06978","600109","LU0359202008.SGD","BK1515","LU0211977185.USD","LU0244354667.USD","01093","BK1610","IE00BPRC5H50.USD","LU0455707207.USD","LU1328277881.USD","02616","02269","LU0314109678.HKD","BK1161","MEDX","LU1242518931.SGD","159992","BK1576","01877","09995","01177","06185","LU2399975544.HKD","06160","LU0052750758.USD","LU0823426308.USD","LU1794554557.SGD","LU2242644610.SGD","BK0201","LU0540923850.HKD","02142","IE0008368742.USD","LU1807302812.USD","LNGR","BK1583","LU1226287875.USD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672790980","title":"港股异动 | 创新药概念股回落 诺诚健华(09969.HK)跌超8% 荣昌生物(09995.HK)跌近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2672790980","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672790980?lang=zh_cn&edition=full","pubTime":"2026-10-02 15:46","pubTimestamp":1790927189,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06978","LU2328871848.SGD","BK1161","BK1583","LU1969619763.USD","BK1574","09995","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175077314","title":"异动解读｜荣昌生物盘中下跌7.65%，报71.0港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175077314","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175077314?lang=zh_cn&edition=full","pubTime":"2026-10-02 09:52","pubTimestamp":1790905951,"startTime":"0","endTime":"0","summary":"10月2日，荣昌生物盘中下跌7.65%，报71.0港元/股，成交额2721.73万港元。荣昌生物所在的生物科技行业中，个股普遍走弱，百济神州跌6.39%，三生制药跌5.73%，科伦博泰生物跌5.42%，信达生物跌4.69%，康方生物跌3.68%。荣昌生物制药（烟台）股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司，专注于抗体药物偶联物（ADC）、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域，产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671727907","title":"港股异动 | 荣昌生物(09995)尾盘涨超3% 泰它西普治疗gMG中国Ⅲ期临床研究分析结果在AANEM年会公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2671727907","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671727907?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:49","pubTimestamp":1790754545,"startTime":"0","endTime":"0","summary":"消息面上，据荣昌生物官微消息，9月29日，荣昌生物泰它西普治疗全身型重症肌无力中国Ⅲ期临床研究的一项最新事后分析结果，在2026年美国神经肌肉与电诊断医学协会年会期间的重症肌无力基金会科学会议上，以口头报告形式公开发布。近期，Vor Bio宣布泰它西普治疗gMG的全球Ⅲ期临床研究已完成患者入组，该研究24周主要终点的顶线结果预计于2027年上半年公布。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1161","LU1969619763.USD","BK1583","09995","BK4585","LU2148510915.USD","BK1574","VXUS","BK0239","LU1064131003.USD","688331","LU2328871848.SGD","KCAI","LU2488822045.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671293354","title":"创新药概念股逆市走强 康方生物（09926）涨16.85%、康诺亚-B（02162）涨10.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671293354","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671293354?lang=zh_cn&edition=full","pubTime":"2026-09-29 13:20","pubTimestamp":1790659249,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念股逆市走强，康方生物 涨16.85%，康诺亚-B涨10.32%，乐普生物涨7.88%，荣昌生物涨5.41%，科伦博泰生物涨5.32%，博安生物涨4.74%，恒瑞医药涨4.02%，再鼎医药涨4.02%。根据Insight数据，除已经在美国获批上市的药物外，已达成出海合作的国产创新药中有27款处于临床后期。其中，依沃西单抗、匹米替尼已在美国申请上市，芦康沙妥珠单抗、伦康依隆妥单抗、SSGJ-707等重点品种处于临床III期。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992749","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","IE00BPRC5H50.USD","LU2328871848.SGD","BK1574","09688","159992","09926","BK1588","MEDX","IE00B543WZ88.USD","LU1969619763.USD","BK1191","LU0359201885.HKD","LU0417516571.SGD","LU0634319403.HKD","02162","BK1161","06955","LU1720050803.USD","KURE","LU0348766576.USD","BK1587","LU0348783233.USD","LU0417516902.SGD","LU0196878994.USD","LU0348735423.USD","LU0348767384.USD","LU0348827113.USD","LU0359201612.USD","LU1023057109.AUD","02157","LU2476274308.USD","IBBQ","LU0417516738.SGD","LNGR","LU0348825331.USD","09995","LU1794554557.SGD","LU2488822045.USD","LU2476274720.SGD","LU0348784397.USD","06990","IE00B5MMRT66.SGD","LU0359202008.SGD","LU0561508036.HKD","01276","LU2543165471.USD","BK1583","LU2778985437.USD","LU1961090484.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172869077","title":"异动解读｜荣昌生物盘中上涨5.13%，报74.85港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172869077","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172869077?lang=zh_cn&edition=full","pubTime":"2026-09-29 10:45","pubTimestamp":1790649955,"startTime":"0","endTime":"0","summary":"9月29日，荣昌生物盘中上涨5.13%，报74.85港元/股，成交额1.46亿港元。荣昌生物所在的生物科技行业中，个股普遍走强，康方生物涨13.37%，康诺亚-B涨7.52%，三生制药涨1.02%，百济神州涨0.64%，信达生物持平。荣昌生物制药（烟台）股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司，专注于抗体药物偶联物（ADC）、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域，产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670536032","title":"荣昌生物（688331）披露公司秘书及授权代表变更公告，9月28日股价下跌0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670536032","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670536032?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:07","pubTimestamp":1790604469,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，荣昌生物报收于115.34元，较前一交易日下跌0.81%，最新总市值为651.07亿元。近日，荣昌生物发布公告称，董事会宣布童少靖先生已获香港联交所确认具备担任公司秘书的资格。谭柏如女士已辞任公司联席公司秘书及根据上市规则第3.05条委任的授权代表，自2026年9月28日起生效。谭女士将继续担任公司条例项下在香港接受法律程序文件的授权代表。董事会对谭女士的贡献表示感谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800034351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU1064131003.USD","LU2148510915.USD","LU2488822045.USD","BK1583","BK0239","LU1969619763.USD","688331","BK1574","LU2328871848.SGD","BK1161","09995"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0639},{"period":"1month","weight":-0.1077},{"period":"3month","weight":-0.1357},{"period":"6month","weight":-0.4504},{"period":"1year","weight":-0.3107},{"period":"ytd","weight":-0.0847}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0153},{"period":"6month","weight":-0.0754},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":-0.0563}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"荣昌生物制药（烟台）股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物（ADC）、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":0.012545},{"month":4,"riseRate":0.833333,"avgChangeRate":0.095268},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.049233},{"month":6,"riseRate":0.666667,"avgChangeRate":0.089626},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.010221},{"month":8,"riseRate":0.333333,"avgChangeRate":0.055035},{"month":9,"riseRate":0.5,"avgChangeRate":0.07525},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.001007},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"荣昌生物","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,09995,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}